EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evaluation of the DAMSUN-HF trial: the role of an artificial intelligence stethoscope in detecting reduced ejection fraction in patients living in a low-resource region

Dmitry Abramov, Baljash S Cheema, Kalliopi Keramida, Kaveh Hosseini, Marat Fudim, Abdul Mannan Khan Minhas

Heart Failure Reviews · 2026

DOI: 10.1007/s10741-025-10591-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, 2026. Verfasst von Dmitry Abramov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Loma Linda University Health, Loma Linda, CA, USA. Dabramov@llu.edu. Hauptthemen laut MEDLINE: Artificial Intelligence, Heart Failure, Stroke Volume, Stethoscopes. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Loma Linda University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evaluation of ejection fraction (EF) is paramount for patients with symptoms of heart failure. While transthoracic echocardiography (TTE) is the most common way to evaluate EF, recent advances in artificial intelligence (AI) have opened the door for alternative methods to screen for reduced EF with smaller and more portable technology. The DAMSUN-HF study evaluated the accuracy of an AI-based stethoscope for detecting reduced EF (≤40%) in patients with symptoms of heart failure in a region with geographic and economic barriers to obtaining timely TTE. This mini-review examines the DAMSUN-HF study and highlights the potential clinical implications of the study findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceHeart FailureStroke VolumeStethoscopesHumansEchocardiography

Stichwörter der Autor:innen

Artificial intelligenceEchocardiographyEjection fractionHeart failure

Autor:innen und Institutionen

  • Division of Cardiology, Loma Linda University Health, Loma Linda, CA, USA. Dabramov@llu.edu.
  • Center for Artificial Intelligence, Northwestern Medicine, Bluhm Cardiovascular Institute, Chicago, IL, USA.
  • Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Cardiology Department, General Anti-Cancer Oncological Hospital Agios Savvas, Athens, Greece.
  • Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens Medical School, Athens, Greece.
  • Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.

Förderung

  • Loma Linda University

Zitieren

APA

Abramov, D., Cheema, B. S., Keramida, K., Hosseini, K., Fudim, M., & Minhas, A. M. K. (2026). Evaluation of the DAMSUN-HF trial: the role of an artificial intelligence stethoscope in detecting reduced ejection fraction in patients living in a low-resource region. Heart Failure Reviews. https://doi.org/10.1007/s10741-025-10591-2

Vancouver

Abramov D, Cheema BS, Keramida K, Hosseini K, Fudim M, Minhas AMK. Evaluation of the DAMSUN-HF trial: the role of an artificial intelligence stethoscope in detecting reduced ejection fraction in patients living in a low-resource region. Heart Failure Reviews. 2026. doi:10.1007/s10741-025-10591-2

BibTeX
@article{Abramov2026,
  author = {Abramov, Dmitry and Cheema, Baljash S and Keramida, Kalliopi and Hosseini, Kaveh and Fudim, Marat and Minhas, Abdul Mannan Khan},
  title = {Evaluation of the DAMSUN-HF trial: the role of an artificial intelligence stethoscope in detecting reduced ejection fraction in patients living in a low-resource region},
  journal = {Heart Failure Reviews},
  year = {2026},
  doi = {10.1007/s10741-025-10591-2}
}
Kostenlos starten →